PSCH Holdings

75 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.

Top 25 Holdings

#HoldingWeightShares (as reported)Value (as reported)
1Glaukos Corp5.53%55,939$9.6M
2Protagonist Therapeutics Inc4.96%61,369$8.6M
3TG Therapeutics Inc4.09%134,516$7.1M
4Alkermes PLC3.78%159,075$6.6M
5Ligand Pharmaceuticals Inc3.18%18,903$5.5M
6PTC Therapeutics Inc2.87%79,123$5.0M
7Teleflex Inc2.87%40,167$5.0M
8Merit Medical Systems Inc2.76%56,607$4.8M
9RadNet Inc2.64%67,141$4.6M
10Concentra Group Holdings Parent Inc2.35%112,407$4.1M
11Integer Holdings Corp2.34%32,224$4.1M
12Indivior Pharmaceuticals Inc2.32%111,864$4.0M
13ICU Medical Inc2.12%23,705$3.7M
14Amneal Pharmaceuticals Inc1.97%174,924$3.4M
15Organon & Co1.97%248,854$3.4M
16Veracyte Inc1.89%76,189$3.3M
17LifeStance Health Group Inc1.78%255,990$3.1M
18Waystar Holding Corp1.69%114,462$2.9M
19TransMedics Group Inc1.53%32,854$2.7M
20National HealthCare Corp1.53%12,015$2.7M
21Arcutis Biotherapeutics Inc1.50%108,376$2.6M
22Acadia Healthcare Co Inc1.48%88,186$2.6M
23AtriCure Inc1.47%48,199$2.6M
24Privia Health Group Inc1.41%120,984$2.5M
25Neogen Corp1.39%206,612$2.4M

Sector Weights

  • Financial Services: 1.10%
  • Healthcare: 98.90%

Country Weights

  • United States: 96.17%
  • Ireland: 3.80%
  • Other: 0.03%

Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.